In a head-to-head test of two popular cholesterol-lowering statin drugs — Lipitor and Crestor — both medications worked equally well. Lipitor (atorvastatin) and Crestor (rosuvastatin) both effectively ...
Rosuvastatin tied to cardiovascular and mortality benefits but also higher risk for type 2 diabetes. (HealthDay News) — There are small but important differences in risk for some clinical outcomes ...
LONDON (MarketWatch) -- AstraZeneca said it's going to launch the first head-to-head study comparing Crestor at 40 milligram doses with Pfizer's Lipitor at 80 milligrams, on the progression of ...
Shares in AstraZeneca shed 2.8 percent, the third biggest FTSE 100 faller, with the index down 1.3 percent, after the firm's key cholesterol drug Crestor failed to beat rival Pfizer's Lipitor in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback